Sun Pharma

Sun Pharma News

Sun Pharma posts Q2 net profit of Rs 1,064.09 crore

Sun Pharma said its active pharmaceutical ingredients (API) clocked external sales of Rs 468 crore, up 10 per cent over the same quarter last fiscal.

Sector scan: Sun Pharma set to shut down part of Vadodara R&D unit, 80 staff may lose jobs

In a letter to employees about the move, parts of which The Indian Express has viewed, Sun Pharmaceutical has announced it will shut down its Tandalja and Akota CPUs, part of the company’s Vadodara Research and Development (R&D) unit.


Sun Pharma tumbles on report of fresh allegations by whistleblower

The complaint, sent to SEBI, is reportedly the second in over a month. The whistleblower alleges that Aditya Medisales Ltd had transactions with Suraksha Realty, controlled by Sun Pharma's co-promoter, Sudhir Valia.

Sun Pharma practices: questions, responses

Later, it was reported that a “potential whistleblower” too had raised such questions. Between November 30 and December 6, Sun’s stock price at the National Stock Exchange fell 14.7%.

Sun Pharma gets approval from US FDA for prostrate cancer drug

Sun Pharma's drug is a formulation to be used for the treatment of patients with metastatic castration-resistant prostate cancer.

SC tells MCIA to appoint arbitrator in global dispute

This is the first time in India when a court in the country has invoked section 11 of the Arbitration and Conciliation Act, 2015, asking an independent body to appoint an arbitrator in a matter.


Sun Pharma, ICGEB to develop botanical drug for dengue

Through this agreement, Sun Pharma commits development of Cissampelos pariera (Cipa), a botanical drug, in collaboration with ICGEB, the company said in a statement.

Sun Pharma shares up 2% as company gets USFDA nod for BromSite

The stock gained 1.74 per cent to Rs 825.95 on BSE.

Foreign investors lap up stake sold by Daiichi in Sun Pharma

The Japanese firm sold its entire 8.9 per cent stake in Sun Pharma for an estimated Rs 20,420 crore.

Daiichi Sankyo to sell stake worth R22,500 crore in Sun Pharma

Daiichi Sankyo received 21.5 crore shares of Sun Pharma following the completion of Sun Pharma’s merger with Ranbaxy Laboratories.